Cochlear Limited (ASX:COH)
128.39
-0.61 (-0.47%)
Oct 9, 2026, 4:11 PM AEST
Cochlear Market Cap
Cochlear has a market cap or net worth of 8.4 billion as of October 9, 2026. It is the 3,236th most valuable company in the world and the 61st biggest in Australia. Its market cap has decreased by 55.67% in one year.
Market Cap
8.40B
Enterprise Value
8.42B
Revenue
2.35B
Global Rank
Country Rank
#61 Australia
PE Ratio
57.11
ChartMarket Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 44.18M to 8.40B, an increase of 18,905.70%. That is a compound annual growth rate of 18.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 8.40B | -50.74% |
| Dec 31, 2025 | 17.05B | -10.12% |
| Dec 31, 2024 | 18.97B | -3.04% |
| Dec 29, 2023 | 19.56B | 45.68% |
| Dec 30, 2022 | 13.43B | -5.54% |
| Dec 31, 2021 | 14.22B | 14.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 4DMedical | 2.41B |
| PolyNovo | 645.94M |
| Imricor Medical Systems | 496.73M |
| EBR Systems | 202.91M |
| Aroa Biosurgery | 181.60M |
| EMVision Medical Devices | 154.31M |
| Saluda Medical | 102.07M |
| Lumos Diagnostics Holdings | 94.48M |